Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 344

The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.

Transforming growth factor-β in myocardial disease

Frangogiannis, Nikolaos G.·2022·Nature Reviews Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-021-00646-w

Cites

296 of 296 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 296 references

Research works printed but not linked: 19

  1. Wenzel, S. et al. TGF-β1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes. Basic Res. Cardiol. 105, 621–629 (2010). · doi:10.1007/s00395-010-0108-1
  2. Baxter, G. F., Mocanu, M. M., Brar, B. K., Latchman, D. S. & Yellon, D. M. Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J. Cardiovasc. Pharmacol. 38, 930–939 (2001). · DOI
  3. Kitamura, M., Suto, T., Yokoo, T., Shimizu, F. & Fine, L. G. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156, 2964–2971 (1996). · doi:10.4049/jimmunol.156.8.2964
  4. Dambrink, J. H. et al. Left ventricular dilatation and high-grade ventricular arrhythmias in the first year after myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study. J. Card. Fail. 1, 3–11 (1994). · doi:10.1016/1071-9164(94)90003-5
  5. Lee, H. J., Lee, J. K., Miyake, S. & Kim, S. J. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-β signaling by blocking TGF-β-induced formation of Smad3-Smad4 complexes. J. Biol. Chem. 279, 2666–2672 (2004). · doi:10.1074/jbc.m310591200
  6. Kumar, A. G. et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95, 693–700 (1997). · doi:10.1161/01.cir.95.3.693
  7. Aziz, T. M., Burgess, M. I., Haselton, P. S., Yonan, N. A. & Hutchinson, I. V. Transforming growth factor β and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidence. J. Heart Lung Transpl. 22, 663–673 (2003). · doi:10.1016/s1053-2498(02)00657-5
  8. Boluyt, M. O., Bing, O. H. & Lakatta, E. G. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur. Heart J. 16 (Suppl. N), 19–30 (1995). · doi:10.1093/eurheartj/16.suppl_n.19
  9. Watkins, S. J., Borthwick, G. M., Oakenfull, R., Robson, A. & Arthur, H. M. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. Hypertens. Res. 35, 393–398 (2012). · doi:10.1038/hr.2011.196
  10. Wenzel, S., Muller, C., Piper, H. M. & Schluter, K. D. p38 MAP-kinase in cultured adult rat ventricular cardiomyocytes: expression and involvement in hypertrophic signalling. Eur. J. Heart Fail. 7, 453–460 (2005). · doi:10.1016/j.ejheart.2004.07.001
  11. Heger, J., Peters, S. C., Piper, H. M. & Euler, G. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes. J. Cell Physiol. 220, 515–523 (2009). · doi:10.1002/jcp.21805
  12. Schneiders, D., Heger, J., Best, P., Michael Piper, H. & Taimor, G. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovasc. Res. 67, 87–96 (2005). · doi:10.1016/j.cardiores.2005.02.021
  13. Derangeon, M. et al. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. Cardiovasc. Res. 113, 464–474 (2017). · doi:10.1093/cvr/cvx026
  14. Li, G. et al. Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. Circulation 98, II144–II149 (1998). discussion II149-150.
  15. Pino-Marin, A. et al. Chagas cardiomyopathy: from Romaña sign to heart failure and sudden cardiac death. Pathogens 10, 505 (2021). · doi:10.3390/pathogens10050505
  16. Cruz, J. S., Machado, F. S., Ropert, C. & Roman-Campos, D. Molecular mechanisms of cardiac electromechanical remodeling during Chagas disease: role of TNF and TGF-β. Trends Cardiovasc. Med. 27, 81–91 (2017). · doi:10.1016/j.tcm.2016.08.003
  17. Samudio, M. et al. Local and systemic cytokine expression during experimental chronic Trypanosoma cruzi infection in a Cebus monkey model. Parasite Immunol. 21, 451–460 (1999). · doi:10.1046/j.1365-3024.1999.00242.x
  18. Stauber, A. J., Credille, K. M., Truex, L. L., Ehlhardt, W. J. & Young, J. K. Nonclinical safety evaluation of a transforming growth factor β receptor I kinase inhibitor in Fischer 344 rats and beagle dogs. J. Clin. Pract. 4, 1000196 (2014).
  19. Chen, H., Li, D., Saldeen, T. & Mehta, J. L. TGF-β1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am. J. Physiol. Heart Circ. Physiol. 284, H1612–H1617 (2003). · doi:10.1152/ajpheart.00992.2002

Cited by

See all 344

Metadata

Authors
Frangogiannis, N. G.
Venue
Nature Reviews Cardiology
Published
2022-01-04
Volume
19
Issue
7
Pages
435-455
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W4205403685
Cited by
344
References
296
FWCI
19.89
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transforming growth factor-β in myocardial disease. https://app.cochat.ai/papers/10.1038/s41569-021-00646-w
The paper
Frangogiannis, N. G. (2022). Transforming growth factor-β in myocardial disease. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-021-00646-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.